Approximations of the target-mediated drug disposition model and identifiability of model parameters
The DOI matches its Crossref record; 5 of the 6 references it cites were found in a registry or an index.
Abstract
Models for drugs exhibiting target-mediated drug disposition (TMDD) play an important role in the investigation of biological products (Mager and Jusko 2001). These models are often overparameterized and difficult to converge. A simpler quasi-equilibrium (QE) approximation of the general model has been suggested (Mager and Krzyzanski 2005), but even this simpler form can be overparameterized when, for example, drug target level is not available. This work (a) introduces quasi-steady-state (QSS) and Michaelis-Menten (MM) approximations of the TMDD model, (b) derives the relationships between the parameters of the TMDD, QE, QSS and MM models, (c) investigates the parameter ranges where the simplified approximations are equivalent to the TMDD model, (d) proposes an algorithm for establishing identifiability of these models, and (e) tests this algorithm on simulated datasets. The proposed QSS approximation is more general than the QE approximation: it degenerates into the QE approximation when the internalization rate of the drug-target complex is much smaller than its dissociation rate. The proposed identifiability analysis algorithm may be applied to provide justification for use of simplified approximations, avoiding use of incorrect parameter estimates of over-parameterized TMDD models while simultaneously saving time and resources required for the pharmacokinetics analysis of drugs with TMDD. The utility of the derived approximations and of the identifiability algorithm was demonstrated on the examples of the simulated data sets. The simulation examples indicated that the QSS model may be preferable to the QE model when the internalization rate of the drug-target complex significantly exceeds its dissociation rate. The MM approximation may be adequate when the drug concentration significantly exceeds the target concentrations or when the target occupancy is close to 100%.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A practical constraint in biologics first-in-human modelling is that not all of these disposition parameters can be identified simultaneously. FcRn-mediated linear clearance and central volume of distribution generally scale reliably from non-human primate data and can be estimated with reasonable confidence, whereas TMDD parameters such as target baseline concentration, target turnover, and”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [51]
In the citing paper
“For biologics in particular, this also recognizes that not all parameters are simultaneously identifiable: FcRn-mediated linear clearance and central volume can be carried from non-human primate data, whereas poorly identifiable TMDD parameters are fixed to in vitro or literature values rather than estimated [50,51] (Section 4.5).”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [51]
Citations
Cites
Enzyme kinetics; behavior and analysis of rapid equilibrium and steady state enzyme systems
(1994) · International Journal of Biochemistry · doi:10.1016/0020-711x(94)90021-3 · Cited by 2,972
General Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition
Mager, D. E., & Jusko, W. J. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1014414520282 · Cited by 605
Quasi-Equilibrium Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition
Mager, D. E., & Krzyzanski, W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-6650-0 · Cited by 225 · cited 1×
“Methods Two approximations of the TMDD model were derived: The Quasi-Steady-State (QSS) model was obtained similarly to the Quasi-Equilibrium (QE) model [2] with the assumption of quasi-equilibrium of the free drug, target and complex replaced by the assumption of quasi-stationarity of these entities.”
MethodHayashi, N., Tsukamoto, Y., Sallas, W. M., & Lowe, P. J. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02803.x · Cited by 173
Cited by
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
Dirks, N. L., & Meibohm, B. (2010) · Clinical Pharmacokinetics · doi:10.2165/11535960-000000000-00000 · Cited by 500
Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
Liu, L. (2018) · Protein & Cell · doi:10.1007/s13238-017-0408-4 · Cited by 390
“For this reason, many analyses use empirical approaches for building models that require less information about the drug target interaction, receptor numbers, and turnover rates (Dua et al., 2015; Gibiansky et al., 2008; Grimm, 2009; Mager, 2006).”
BackgroundMethodDostalek, M., Gardner, I., Gurbaxani, B. M., Rose, R. H., & Chetty, M. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-012-0027-4 · Cited by 230
“In particular, these approximations have advantages of fewer parameters, which can be important as it is often difficult to achieve model convergence when trying to fit observed plasma pharmacokinetic data to the full TMDD model [353].”
BackgroundMethodInfluentialA Tutorial on Target-Mediated Drug Disposition (TMDD) Models
Dua, P., Hawkins, E., & van der Graaf, P. (2015) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.41 · Cited by 162
Dong, J. Q., Salinger, D. H., Endres, C. J., Gibbs, J. P., Hsu, C.-P., Stouch, B. J., Hurh, E., & Gibbs, M. A. (2011) · Clinical Pharmacokinetics · doi:10.2165/11537430-000000000-00000 · Cited by 156
“A TMDD model, however, typically requires additional data on the target (ligand or receptor) and/or drug-target complex levels to avoid issues of identifiability of the TMDD model parameters.([45,46]) Due to lack of such data in the literature as well as for the majority of the proprietary compounds, the validity of t…”
Background
Metadata
- Authors
- Gibiansky, L., Gibiansky, E., Kakkar, T., & Ma, P.
- Affiliations
- Icon (United States) (US)
- Amgen (United States) (US)
- Corresponding author
- Gibiansky, Leonid
- Venue
- Journal of Pharmacokinetics and Pharmacodynamics
- Published
- 2008-10
- Volume
- 35
- Issue
- 5
- Pages
- 573-591
- ISSN
- 1567-567X (ISSN-L)
- 1573-8744
- OpenAlex
- W2164977460
- Cited by
- 272
- References
- 6
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 19 · 2023: 9 · 2022: 14 · 2021: 9 · 2020: 16 · 2019: 19 · 2018: 15 · 2017: 23 · 2016: 14 · 2015: 20 · 2014: 14 · 2013: 9 · 2012: 18
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Pharmacokinetics and Pharmacodynamics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- target-mediated drug disposition, quasi-steady-state approximation, quasi-equilibrium approximation, parameter identifiability, overparameterized models, target occupancy, pharmacokinetic modeling, model reduction
- MeSH terms
- Algorithms, Animals, Computer Simulation, Pharmaceutical Preparations, Humans, Models, Biological, Pharmacokinetics, Drug Delivery Systems, Nonlinear Dynamics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Approximations of the target-mediated drug disposition model and identifiability of model parameters. https://app.cochat.ai/papers/10.1007/s10928-008-9102-8
- The paper
- Gibiansky, L., Gibiansky, E., Kakkar, T., & Ma, P. (2008). Approximations of the target-mediated drug disposition model and identifiability of model parameters. Journal of Pharmacokinetics and Pharmacodynamics. https://doi.org/10.1007/s10928-008-9102-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.